Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)

Kookjeon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	166,008	168,844	172,478	306,192	324,839	537,308
Market Cap Growth	5.64%	-2.11%	-43.67%	-5.74%	-39.54%	-
Enterprise Value	180,919	189,611	178,557	319,290	284,635	-
Last Close Price	3075.00	3365.00	3515.00	6222.17	6590.26	10900.81
PE Ratio	-	-	99.34	63.47	36.30	133.06
PS Ratio	1.27	1.29	1.26	2.51	3.13	6.30
PB Ratio	1.73	1.76	1.77	3.14	3.52	6.46
P/TBV Ratio	1.75	1.78	1.80	3.22	3.60	6.50
P/FCF Ratio	22.15	22.53	82.14	-	-	-
P/OCF Ratio	15.65	15.92	17.31	-	-	176.63
EV/Sales Ratio	1.38	1.45	1.31	2.62	2.75	-
EV/EBITDA Ratio	69.87	71.19	32.63	33.11	57.72	-
EV/EBIT Ratio	-	-	486.92	49.05	81.60	-
EV/FCF Ratio	24.14	25.30	85.04	-	-	-
Debt / Equity Ratio	0.48	0.48	0.67	0.81	0.64	0.09
Debt / EBITDA Ratio	17.23	17.23	11.94	8.17	12.03	1.09
Debt / FCF Ratio	6.13	6.13	31.11	-	-	-
Net Debt / Equity Ratio	0.16	0.16	0.19	0.14	-0.39	-0.38
Net Debt / EBITDA Ratio	5.77	5.77	3.38	1.45	-7.22	-4.35
Net Debt / FCF Ratio	2.05	2.05	8.81	-0.31	1.22	4.26
Asset Turnover	0.67	0.67	0.62	0.58	0.68	-
Inventory Turnover	5.02	5.02	4.22	4.05	4.62	-
Quick Ratio	0.82	0.82	0.85	0.94	1.67	2.72
Current Ratio	1.13	1.13	1.19	1.24	2.02	3.52
Return on Equity (ROE)	-4.98%	-4.98%	0.55%	4.95%	10.12%	-
Return on Assets (ROA)	-0.82%	-0.82%	0.10%	1.93%	1.44%	-
Return on Invested Capital (ROIC)	-2.22%	-2.26%	0.20%	7.75%	5.15%	9.38%
Return on Capital Employed (ROCE)	-2.30%	-2.30%	0.30%	5.20%	2.80%	7.20%
Earnings Yield	-2.59%	-2.55%	1.01%	1.58%	2.76%	0.75%
FCF Yield	4.51%	4.44%	1.22%	-14.46%	-9.02%	-1.37%
Payout Ratio	-	-	28.26%	-	5.48%	-
Buyback Yield / Dilution	-0.51%	-0.51%	-1.09%	4.23%	-16.16%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.